ES2088224T3 - Composicion farmaceutica para inhibir la agregacion plaquetaria. - Google Patents

Composicion farmaceutica para inhibir la agregacion plaquetaria.

Info

Publication number
ES2088224T3
ES2088224T3 ES93300737T ES93300737T ES2088224T3 ES 2088224 T3 ES2088224 T3 ES 2088224T3 ES 93300737 T ES93300737 T ES 93300737T ES 93300737 T ES93300737 T ES 93300737T ES 2088224 T3 ES2088224 T3 ES 2088224T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
platelet aggregation
inhibit
alkyl group
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93300737T
Other languages
English (en)
Inventor
Akio Odawara
Yasuhiko Sasaki
Sakae Murata
Hiroshi Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2088224T3 publication Critical patent/ES2088224T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA PARA INHIBIR LA AGREGACION DE TROMBOCITOS QUE CONTIENE 5-(2-CLOROBENCILO)4,5,6,7-TETRAHIDROTIENO[3,2-C]PIRIDINA O UNA SAL DE LA MISMA ACEPTABLE FARMACEUTICAMENTE Y UN DERIVADO 1,5-BENZOTIAZEPINA DE LA FORMULA: EN LA QUE R1 ES UN GRUPO ALQUILO MAS BAJO O UN GRUPO ALCOXI MAS BAJO, R2 ES UN GRUPO ALCANOILO MAS BAJO, R3 Y R4 SON UN GRUPO ALQUILO MAS BAJO Y R5 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO MAS BAJO O UN ATOMO DE HALOGENO, O UNA SAL DE LA MISMA ACEPTABLE FARMACEUTICAMENTE.
ES93300737T 1992-02-06 1993-02-02 Composicion farmaceutica para inhibir la agregacion plaquetaria. Expired - Lifetime ES2088224T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6790192 1992-02-06

Publications (1)

Publication Number Publication Date
ES2088224T3 true ES2088224T3 (es) 1996-08-01

Family

ID=13358264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300737T Expired - Lifetime ES2088224T3 (es) 1992-02-06 1993-02-02 Composicion farmaceutica para inhibir la agregacion plaquetaria.

Country Status (12)

Country Link
US (1) US5382577A (es)
EP (1) EP0555042B1 (es)
JP (1) JP2712144B2 (es)
KR (1) KR100187997B1 (es)
AT (1) ATE136216T1 (es)
CA (1) CA2087743C (es)
DE (1) DE69302035T2 (es)
DK (1) DK0555042T3 (es)
ES (1) ES2088224T3 (es)
GR (1) GR3019791T3 (es)
HK (1) HK1000122A1 (es)
TW (1) TW276997B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637582A (en) * 1992-10-23 1997-06-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
DK0595526T3 (da) * 1992-10-23 1997-10-13 Tanabe Seiyaku Co Middel til at forbedre perifær cirkulation
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
US5872128A (en) * 1997-10-15 1999-02-16 Invamed, Inc. Stabilized composition of ticlopidine hydrochloride
KR100258018B1 (ko) * 1997-12-23 2000-07-01 유승필 티클로피딘과 은행잎 추출물을 함유한 약제조성물
DE69926750T2 (de) * 1998-06-17 2006-06-29 Bristol-Myers Squibb Co. Vorbeugung des hirninfarkts durch kombinierte verabreichung von adp-rezeptor antiblutplättchen und antihypertensiven medikamenten
RU2262933C2 (ru) 2000-12-25 2005-10-27 Санкио Компани, Лимитед Медицинские композиции, содержащие аспирин
US6706658B2 (en) * 2001-12-21 2004-03-16 Engelhard Corporation Catalyst for purification of aromatic acids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
FR2215948B1 (es) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
JP2520119B2 (ja) * 1986-03-18 1996-07-31 名古屋アイ・イ−・シ−株式会社 流体の集中配送装置
DE3626097A1 (de) * 1986-07-31 1988-02-11 Goedecke Ag Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure
JPH0228594A (ja) * 1988-06-13 1990-01-30 Mitsubishi Nuclear Fuel Co Ltd 下部ノズルの取付装置
JPH078799B2 (ja) * 1990-09-17 1995-02-01 田辺製薬株式会社 血小板凝集抑制組成物
JPH078798B2 (ja) * 1990-09-17 1995-02-01 田辺製薬株式会社 血小板凝集抑制組成物

Also Published As

Publication number Publication date
EP0555042B1 (en) 1996-04-03
DK0555042T3 (da) 1996-08-19
ATE136216T1 (de) 1996-04-15
EP0555042A1 (en) 1993-08-11
GR3019791T3 (en) 1996-07-31
KR930017581A (ko) 1993-09-20
DE69302035T2 (de) 1996-08-29
DE69302035D1 (de) 1996-05-09
US5382577A (en) 1995-01-17
TW276997B (es) 1996-06-01
KR100187997B1 (ko) 1999-06-01
CA2087743C (en) 1999-04-27
HK1000122A1 (en) 1997-12-12
JPH05279257A (ja) 1993-10-26
JP2712144B2 (ja) 1998-02-10
CA2087743A1 (en) 1993-08-07

Similar Documents

Publication Publication Date Title
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
PH22136A (en) Dihydropyridazinone derivatives and use thereof
PL333463A1 (en) Novel applications of 1,3-propanodiole derivatives
ES2088224T3 (es) Composicion farmaceutica para inhibir la agregacion plaquetaria.
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
ES2057777T3 (es) Composicion farmaceutica para inhibir la agregacion plaquetaria.
CO4340691A1 (es) 2-HETEROARIL-5,11-DIHIDRO-6H-DIPIRIDO(3,2-b:2´, 3´ -e) (1, 4)-DIAZEPINAS .
GR3023276T3 (en) Preparation of 2-(2-thienyl) ethylamine and synthesis of thieno [3,2-C] pyridine derivatives therefrom
IE901104L (en) New bronchospasmolytic compounds and process for their¹preparation
PT904783E (pt) Derivados de benzo(b)tiofeno para baixar o numero de plaquetas
DE69200862D1 (de) N-2-Chlorbenzyl-2-oxo- und N-2-Chlorbenzyl-2,2,-dioxo-1,2,3-Oxathiazolidinderivate, ihre Herstellung und ihre Verwendung in der Synthese von Thieno[3,2-c]pyridinderivaten.
ATE105565T1 (de) Pradimicinderivate.
IL87107A (en) 2-(4-alkoxyphenyl)-5 (2-aminoethyl)-4-oxo- 3-naphtho- (2, 1b) -1,4-thiazepinone derivatives, their preparation and pharmaceutical compositions containing them
IL113309A0 (en) Imidazopyridine derivatives, their preparation and use
EP0739894A4 (en) THIAZOLINE DERIVATIVE

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555042

Country of ref document: ES